Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising improvements across several clinical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, more reputable different for therapeutic use, specially in